SCHEMBL24353025

SCHEMBL24353025

O[C@@H](COc1ccc(S)cc1)C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40
APH1A Q96BI3 1/20 0.40
PSENEN Q9NZ42 1/20 0.40
MAPT P10636 3/20 0.40
LMNA P02545 2/20 0.40
POLB P06746 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP1A2 P05177 1/20 0.38
CETP P11597 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 1/20 0.35
HTT P42858 2/20 0.34
ATM Q13315 1/20 0.34
HIF1A Q16665 1/20 0.34
AR P10275 1/20 0.33
MGLL Q99685 1/20 0.33
ABHD6 Q9BV23 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24352244 0.81 USP2 (0.50) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6527647 0.81 APP (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL21910786 0.79 CETP (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL10204660 0.79 ALDH1A1 (0.44) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL24352861 0.79 KMT2A (0.49) MAPTLMNAPOLBNPSR1SMN1; SMN2
SCHEMBL24352245 0.79 KMT2A (0.49) MAPTLMNAPOLBNPSR1SMN1; SMN2
SCHEMBL28601887 0.78 CETP (0.38) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6527642 0.77 PARP10 (0.54) MAPTLMNAPOLBNPSR1ALDH1A1
SCHEMBL21811075 0.77 MAPT (0.40) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL23815018 0.77 PSEN1 (0.38) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119395-A1 BICYCLIC COMPOUNDS ALIGOS THERAPEUTICS, INC. 2022-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119395-A1 BICYCLIC COMPOUNDS SLC10A1, PKD1, CYP11B2 PSEN1 766/4885PSEN2 774/4885APH1B 2306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.